Q2 2025 Rossari Biotech Ltd Earnings Call Transcript
Key Points
- Rossari Biotech Ltd (BOM:543213) reported a steady quarter with a 3% increase in revenues to INR498.4 crore.
- The HPPC division showed a year-over-year growth of 6%, with revenues reaching INR390 crore.
- Exports grew by 32% in H1 FY'25, significantly supporting overall performance despite softer domestic growth.
- The company has made strategic investments, including the establishment of Rossari Biotech Trading FZE in the UAE and the acquisition of Unistar Thai Company Limited.
- Rossari Biotech Ltd (BOM:543213) is focusing on sustainability, having installed solar capacity, reduced water consumption, and implemented waste management initiatives.
- The textile specialty chemicals division faced headwinds, with revenues declining from INR96 crore to INR84 crore.
- Domestic sales remained flat, with the HPPC division experiencing softer growth due to flat FMCG home care volumes and pricing pressures.
- The company faced challenges in the Bangladesh and Egypt markets, impacting textile exports.
- Increased freight costs and professional expenses have impacted margins, despite improvements in gross profit.
- The animal health and nutrition business did not meet expected growth targets, with strategic shifts impacting revenue.
Ladies and gentlemen, good day and welcome to the Rossari Biotech Limited earnings conference call. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing star then zero on your touchtone phone. Please note that this conference is being recorded. I now hand the conference over to Mr Anup Poojari from CDR India. Thank you and over to you Mr Poojari.
Thank you. Good evening, everyone and thank you for joining us on Rossari Biotech Q2 F 525 earnings conference call we have with us, Mr Edward Menezes Promoter and Executive Chairman and Mr Ketan Sablok Group, Chief Financial Officer of the company. We'll begin the call with opening remarks from the management calling following which we'll have the forum open for a question and answer session. Before we start, I would like to point out that some statements made in today's call may be forward-looking in nature and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
